- Association of Intravenous vs. Oral Iron Therapy with Risk of Infectious Outcomes in Patients with CKD
10:00 AM - 12:00 PM
Association of Intravenous vs. Oral Iron Therapy with Risk of Infectious Outcomes in Patients with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- IHOPE: A Randomized, Open-Label, Positive-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Oral Iron Polysaccharide Complex in Patients on Hemodialysis
10:00 AM - 12:00 PM
IHOPE: A Randomized, Open-Label, Positive-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Oral Iron Polysaccharide Complex in Patients on Hemodialysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Overexpression of the Iron Regulatory Hormone Erythroferrone Mitigates Anemia and Enhances Kidney Function in a Mouse Model of CKD
10:00 AM - 12:00 PM
Overexpression of the Iron Regulatory Hormone Erythroferrone Mitigates Anemia and Enhances Kidney Function in a Mouse Model of CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Interleukin-6 Inhibition with Clazakizumab on Anemia and Iron Parameters in Patients with Kidney Failure
10:00 AM - 12:00 PM
Effects of Interleukin-6 Inhibition with Clazakizumab on Anemia and Iron Parameters in Patients with Kidney Failure
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Impact of Changes in Hemoglobin on Health-Related Quality of Life in Dialysis Patients
10:00 AM - 12:00 PM
Impact of Changes in Hemoglobin on Health-Related Quality of Life in Dialysis Patients
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Associations of Anemia and Iron Parameters with Fatigue in Persons with and without Kidney Diseases
10:00 AM - 12:00 PM
Associations of Anemia and Iron Parameters with Fatigue in Persons with and without Kidney Diseases
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Exploring the Interplay of Inflammation, Eryptosis, and Anemia in ESKD
10:00 AM - 12:00 PM
Exploring the Interplay of Inflammation, Eryptosis, and Anemia in ESKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Association of Erythropoietin Resistance with Sleep Apnea Syndrome and Prognosis in Patients on Maintenance Hemodialysis
10:00 AM - 12:00 PM
Association of Erythropoietin Resistance with Sleep Apnea Syndrome and Prognosis in Patients on Maintenance Hemodialysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Reduced Flippase Activity in the Early Life of Mature Erythrocytes Is Associated with Their Shortened Lifespan in Renal Anemia
10:00 AM - 12:00 PM
Reduced Flippase Activity in the Early Life of Mature Erythrocytes Is Associated with Their Shortened Lifespan in Renal Anemia
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Mitochondrial Dysfunction in FOXD1 Lineage Cells Has a Key Role in the Development of Anemia Associated with CKD
10:00 AM - 12:00 PM
Mitochondrial Dysfunction in FOXD1 Lineage Cells Has a Key Role in the Development of Anemia Associated with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Protein-Bound Uremic Solute 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid (CMPF) Induces Eryptosis through a Piezo1-Dependent Pathway
10:00 AM - 12:00 PM
Protein-Bound Uremic Solute 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid (CMPF) Induces Eryptosis through a Piezo1-Dependent Pathway
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Prescribing Practices of Erythropoiesis-Stimulating Agents in Dialysis-Dependent and Nondialysis-Dependent CKD
10:00 AM - 12:00 PM
Prescribing Practices of Erythropoiesis-Stimulating Agents in Dialysis-Dependent and Nondialysis-Dependent CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Association of Erythropoietin Resistance Index with Interleukin-6 among Patients Undergoing Conventional and Extended-Hours Haemodialysis
10:00 AM - 12:00 PM
Association of Erythropoietin Resistance Index with Interleukin-6 among Patients Undergoing Conventional and Extended-Hours Haemodialysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Role of Iron Sequestration in the Development of Anemia of CKD: Implications for Treatment Resistance
10:00 AM - 12:00 PM
Role of Iron Sequestration in the Development of Anemia of CKD: Implications for Treatment Resistance
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Iron Sequestration in Kidney Macrophages Is Essential for Protecting Proximal Tubules from Iron Overload during Iron Therapy in CKD
10:00 AM - 12:00 PM
Iron Sequestration in Kidney Macrophages Is Essential for Protecting Proximal Tubules from Iron Overload during Iron Therapy in CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Safety and Effectiveness of Erythropoietin vs. Roxadustat for Anemia in Hemodialysis-Dependent Peridialytic CKD Patients: An Observational, Retrospective, Matched, Real-World Study
10:00 AM - 12:00 PM
Safety and Effectiveness of Erythropoietin vs. Roxadustat for Anemia in Hemodialysis-Dependent Peridialytic CKD Patients: An Observational, Retrospective, Matched, Real-World Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Pegmolesatide for the Treatment of Anemia in Patients with CKD Undergoing Dialysis: Insights from a Randomized Active-Controlled Phase 3 Study
10:00 AM - 12:00 PM
Pegmolesatide for the Treatment of Anemia in Patients with CKD Undergoing Dialysis: Insights from a Randomized Active-Controlled Phase 3 Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Hepcidin Is a Potential Predictor Marker for Anemia Progression in Patients on Hemodialysis
10:00 AM - 12:00 PM
Hepcidin Is a Potential Predictor Marker for Anemia Progression in Patients on Hemodialysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Recombinant Human Erythropoietin (rhEPO)-Fc for Renal Anaemia in Chinese Patients on Haemodialysis: A Multicentre, Randomised, Open-Label, Phase 3 Study
10:00 AM - 12:00 PM
Recombinant Human Erythropoietin (rhEPO)-Fc for Renal Anaemia in Chinese Patients on Haemodialysis: A Multicentre, Randomised, Open-Label, Phase 3 Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Association of Anemia (Hemoglobin <13 g/dL in Men and <12 g/dL in Women) with Long-Term Kidney Prognosis in Patients with ADPKD: Insights from Time Series Analyses
10:00 AM - 12:00 PM
Association of Anemia (Hemoglobin <13 g/dL in Men and <12 g/dL in Women) with Long-Term Kidney Prognosis in Patients with ADPKD: Insights from Time Series Analyses
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Randomized Controlled Trial to Evaluate the Efficacy of Roxadustat Dosing Regimens in Patients with CKD and Anemia on Dialysis
10:00 AM - 12:00 PM
A Randomized Controlled Trial to Evaluate the Efficacy of Roxadustat Dosing Regimens in Patients with CKD and Anemia on Dialysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Single-Centre Prospective Study of Indigenously Developed Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) (Desidustat) for Treatment of Renal Anemia
10:00 AM - 12:00 PM
Single-Centre Prospective Study of Indigenously Developed Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) (Desidustat) for Treatment of Renal Anemia
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Evaluating Therapeutic Potential and Safety Profile of Desidustat for Anaemia Management in Patients with CKD: A Prospective, Open-Label, Single-Centre Study
10:00 AM - 12:00 PM
Evaluating Therapeutic Potential and Safety Profile of Desidustat for Anaemia Management in Patients with CKD: A Prospective, Open-Label, Single-Centre Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Real-World Experience of Hypoxia-Inducing Factor-Prolyl Hydroxylase Inhibitor Desidustat for Anemia in Dialysis-Dependent CKD
10:00 AM - 12:00 PM
Real-World Experience of Hypoxia-Inducing Factor-Prolyl Hydroxylase Inhibitor Desidustat for Anemia in Dialysis-Dependent CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- First-in-Human Study of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) AND017 in Healthy Participants
10:00 AM - 12:00 PM
First-in-Human Study of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) AND017 in Healthy Participants
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Food on the Pharmacokinetics of AND017 in a Phase I Study
10:00 AM - 12:00 PM
Effect of Food on the Pharmacokinetics of AND017 in a Phase I Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Safety and Efficacy of AND017, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in Patients with Nondialysis-Dependent CKD (NDD-CKD)
10:00 AM - 12:00 PM
Safety and Efficacy of AND017, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in Patients with Nondialysis-Dependent CKD (NDD-CKD)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Real-World Evidence of Vadadustat in Patients with Anemia and CKD: Interim Results from Postmarketing Surveillance (VIOLET Survey) in Japan
10:00 AM - 12:00 PM
Real-World Evidence of Vadadustat in Patients with Anemia and CKD: Interim Results from Postmarketing Surveillance (VIOLET Survey) in Japan
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Framework to Assess the Benefits and Risks of Treatments and Dosing Regimens for Anemia of CKD
10:00 AM - 12:00 PM
Framework to Assess the Benefits and Risks of Treatments and Dosing Regimens for Anemia of CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- On-Treatment Analyses of Cardiovascular Safety in the Vadadustat Phase 3 Program
10:00 AM - 12:00 PM
On-Treatment Analyses of Cardiovascular Safety in the Vadadustat Phase 3 Program
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Major Adverse Cardiovascular Events (MACE) in Patients Randomly Assigned to Vadadustat vs. Darbepoetin Alfa during the 3 Months after Dialysis Initiation
10:00 AM - 12:00 PM
Major Adverse Cardiovascular Events (MACE) in Patients Randomly Assigned to Vadadustat vs. Darbepoetin Alfa during the 3 Months after Dialysis Initiation
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Projected Long-Term Cost Savings with Roxadustat, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), among Patients on Hemodialysis: Insights from a 100-Week Longitudinal Study
10:00 AM - 12:00 PM
Projected Long-Term Cost Savings with Roxadustat, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), among Patients on Hemodialysis: Insights from a 100-Week Longitudinal Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Prospective Single-Center Study on Desidustat, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in the Management of Anemia in Dialysis-Dependent CKD
10:00 AM - 12:00 PM
A Prospective Single-Center Study on Desidustat, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in the Management of Anemia in Dialysis-Dependent CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Impact of Roxadustat Kinetic Pharmacodynamics on Starting Dosage for Anemia in Dialysis-Dependent (DD) and Nondialysis-Dependent (NDD) Patients with CKD
10:00 AM - 12:00 PM
Impact of Roxadustat Kinetic Pharmacodynamics on Starting Dosage for Anemia in Dialysis-Dependent (DD) and Nondialysis-Dependent (NDD) Patients with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Efficacy of Desidustat in Increasing and Maintaining Hemoglobin Levels in Anemic Patients with CKD
10:00 AM - 12:00 PM
Efficacy of Desidustat in Increasing and Maintaining Hemoglobin Levels in Anemic Patients with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Safety and Efficacy of Vadadustat in Erythropoiesis-Stimulating Agent-Naïve Patients New to Dialysis Who Have CKD-Related Anemia
10:00 AM - 12:00 PM
Safety and Efficacy of Vadadustat in Erythropoiesis-Stimulating Agent-Naïve Patients New to Dialysis Who Have CKD-Related Anemia
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Long-Term Safety of Vadadustat for Treatment of Anemia-Related CKD in Phase 3 Trials
10:00 AM - 12:00 PM
Long-Term Safety of Vadadustat for Treatment of Anemia-Related CKD in Phase 3 Trials
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Single-Center 1-Year Experience with the Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Desidustat (Oxemia) in Dialysis- and Nondialysis-Dependent Patients with CKD and Anemia
10:00 AM - 12:00 PM
Single-Center 1-Year Experience with the Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Desidustat (Oxemia) in Dialysis- and Nondialysis-Dependent Patients with CKD and Anemia
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Pharmacovigilance Analysis of the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) Events for Belzutifan
10:00 AM - 12:00 PM
Pharmacovigilance Analysis of the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) Events for Belzutifan
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Pharmacovigilance Analysis of the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) Events for Daprodustat
10:00 AM - 12:00 PM
Pharmacovigilance Analysis of the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) Events for Daprodustat
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Reversible Central Hypothyroidism Associated with Roxadustat in Patients Undergoing Hemodialysis
10:00 AM - 12:00 PM
Reversible Central Hypothyroidism Associated with Roxadustat in Patients Undergoing Hemodialysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Cutoff Value of Erythropoiesis-Stimulating Agent Resistance Index at Which Iron Replacement Therapy Is Expected to Be Effective
10:00 AM - 12:00 PM
Cutoff Value of Erythropoiesis-Stimulating Agent Resistance Index at Which Iron Replacement Therapy Is Expected to Be Effective
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Hemoglobin Rate of Rise during Initial Treatment in Nondialysis-Dependent Patients with CKD and Anemia: Secondary Analysis of a Randomized Controlled Study
10:00 AM - 12:00 PM
Hemoglobin Rate of Rise during Initial Treatment in Nondialysis-Dependent Patients with CKD and Anemia: Secondary Analysis of a Randomized Controlled Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Hemoglobin Variability in Nondialysis-Dependent Patients with CKD and Anemia: Secondary Analysis of a Randomized Controlled Study
10:00 AM - 12:00 PM
Hemoglobin Variability in Nondialysis-Dependent Patients with CKD and Anemia: Secondary Analysis of a Randomized Controlled Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Association of Hemoglobin Level with Mortality and Its Effect Modifiers in Patients Undergoing Maintenance Hemodialysis: A Nationwide Cohort Study
10:00 AM - 12:00 PM
Association of Hemoglobin Level with Mortality and Its Effect Modifiers in Patients Undergoing Maintenance Hemodialysis: A Nationwide Cohort Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Treatment of Clinically Meaningful Anemia by Prescriber Type in Nondialysis-Dependent CKD Patients in the United States
10:00 AM - 12:00 PM
Treatment of Clinically Meaningful Anemia by Prescriber Type in Nondialysis-Dependent CKD Patients in the United States
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Clinical Implementation Framework of Anemia Control Model in Singapore
10:00 AM - 12:00 PM
Clinical Implementation Framework of Anemia Control Model in Singapore
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
